Joel Rubenstein, MD, MSc, research scientist at the Veterans Affairs Center of Excellence for Clinical Management Research and Director of the Barrett’s Esophagus Program at the University of Michigan, discusses the recent American Gastroenterological Association guideline on endoscopic eradication therapy for the treatment of Barrett’s esophagus.
As the risk of developing esophageal cancer is higher in patients with the condition, the guideline contains new recommendations for clinicians and patients regarding EET for BE and related neoplasia.
0:10 Connecting BE to Esophageal Cancer
0:49 Previous Guidelines for BE
2:48 EET in High- Versus Low-Grade Dysplasia
5:38 Comparing Stepwise and Focal Endoscopic Mucosal Resection
6:34 Endoscopic Submucosal Versus Mucosal Dissection
8:44 Potential Future Guideline Updates